News

GTT Reports Strong FY 2024 Results with Significant Growth

GTT Reports Strong FY 2024 Results with Significant Growth

GTT's Remarkable Financial Performance in FY 2024

In the recent financial report, GTT has announced an exceptional performance for the financial year 2024. This prominent technology and engineering group, renowned for its innovative membrane containment systems for liquefied gases, has successfully navigated a dynamic and challenging industry landscape, resulting in record sales and noteworthy increases in EBITDA.

Highlights from FY 2024 Results

The financial highlights indicate a significant increase in consolidated revenues, which surged by 50% to reach €641 million, driven largely by the uptick in LNG carriers under construction. This substantial growth also reflects the efficiency of the company's operational strategies, emphasizing their commitment to operational excellence.

Key Figures and Achievements

The order book for GTT stands impressively at nearly €2 billion, showcasing a high level of visibility into future revenues. A total of 72 LNG carrier orders were received in the past year, alongside 12 orders for ethane carriers, underlining the increasing demand for liquefied natural gas.

Furthermore, the consolidated EBITDA rose to €388 million, marking a remarkable increase of 65% compared to the previous year. This growth demonstrates not only the robust sales performance but also the strategic cost management employed by GTT.

Outlook for the Future

Looking ahead, GTT has outlined ambitious targets for the year 2025, projecting consolidated revenues between €750 million and €800 million. Additionally, the company aims to deliver consolidated EBITDA ranging from €490 million to €540 million, highlighting the confidence in its continued growth trajectory.

Dividend Increase

In line with the strong financial performance, GTT's Board of Directors has proposed a dividend of €7.50 per share for the 2024 financial year, which marks a substantial increase of 72% compared to the previous year. This decision underlines GTT's commitment to returning value to its shareholders while maintaining a robust capital structure.

Strategic Developments and Innovations

In addition to financial growth, GTT is actively pursuing various strategic initiatives aimed at enhancing its market position and expanding its technological capabilities. The recent acquisition of VPS, a company specializing in vessel performance management, has significantly strengthened GTT’s digital solutions segment, which has demonstrated an impressive 85% growth in revenue for FY 2024.

Expansion in the LNG Sector

The rising demand for LNG continues to fuel GTT's growth prospects, with anticipated new liquefaction projects and increased shipyard construction capacity. GTT's insights into industry trends have positioned it well within the market, and the company is prepared to meet the growing needs of its clients.

Conclusion

GTT's robust performance in FY 2024 is a testament to its strategic insights and effective operational management. With a strong order book, promising growth forecasts for the upcoming years, and continuous commitment to innovation, GTT is well-positioned to lead the industry in the coming decade.

Frequently Asked Questions

What were GTT's total revenues for FY 2024?

GTT reported consolidated revenues of €641 million for the financial year 2024, a 50% increase from the previous year.

How much did GTT's EBITDA grow in FY 2024?

EBITDA for GTT grew by 65%, amounting to €388 million for the year 2024.

What is the dividend proposed by GTT for FY 2024?

GTT's Board of Directors has proposed a dividend of €7.50 per share, which reflects a 72% increase compared to the previous year.

What is GTT's order book value?

The order book for GTT is nearly €2 billion, providing high revenue visibility for the upcoming years.

What future revenue targets has GTT set for 2025?

GTT aims for consolidated revenues between €750 million and €800 million for 2025, with anticipated EBITDA of €490 million to €540 million.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 194

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 96

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 194

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 222

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 168

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 130

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading

Top 5 Most Recently Viewed Articles

Transformative Innovations in AI-Driven Data Center Patenting

Updated Category News Views 238

Insights from the Latest PatentVest Pulse Report In an era where digital advancements are at an all-time high, PatentVest has unveiled their latest findings in the PatentVest Pulse Report. This enlightening report delves into the transformative trends emerging in the AI data center patent landscape. With growing demands for efficient data handling and innovative...

Continue Reading
TransUnion's Q4 Earnings Beat Expectations; Analysts React

Updated Category News Views 232

TransUnion's Impressive Fourth Quarter Earnings TransUnion reported upbeat earnings for the fourth quarter, showcasing a strong performance that caught the attention of market analysts. The company announced earnings of $1.07 per share, surpassing the analyst consensus estimate of $1.02. In addition, quarterly sales rose to $1.171 billion, exceeding expectations of $1.134...

Continue Reading
Tencent Music Entertainment Group Announces Q3 2025 Results Update

Updated Category News Views 333

Tencent Music Entertainment Group to Report Financial Results Tencent Music Entertainment Group (NYSE: TME), a prominent name in the realm of online music and audio entertainment, has made a significant announcement regarding its upcoming financial results. The company is gearing up to reveal its unaudited financial performance for the third quarter of 2025, a vital time...

Continue Reading
AiDash's New Leadership Team Drives Growth and Innovation

Updated Category News Views 132

AiDash's New Leadership Team Drives Growth and Innovation AiDash, an enterprise SaaS company focused on making critical infrastructure industries climate adaptive and resilient, has recently taken significant steps to expand its leadership team. This move comes at a vital time as the company continues to scale its operations, aiming to meet the rising demand for...

Continue Reading
Daily Market Insights: Trading Strategies for Major Stocks

Updated Category News Views 391

Daily Market Trading Strategies for Success Good morning, traders! Today, we’re diving into insights on crucial stocks such as SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. Our goal is to discuss effective strategies and essential price levels to help you navigate the market with confidence. Market Analysis: Key Price Levels to Watch Using our exclusive formula at...

Continue Reading